After Q1 2025, when we have finished paying the vast majority of our earn outs, we expect significantly higher free cash flow generation and the potential for more rapid delevering. As Trevor stated, delevering is a critical component to increasing free cash flow and we remain committed to doing so. We expect our net leverage will continue to decrease through the end of 2023 And our goal is to delever to 4 times by the end of 2024, a target which includes 2024 estimated earn out payments of Approximately $135,000,000 In addition, given the current interest rate environment, we are adjusting our target net leverage range to 3 to 4 times, down from 3.5 to 4.5 times, which implies incremental deleveraging into 2025. For the Q4 of 2023, we expect revenue of $275,000,000 to $285,000,000 Organic growth of 12% to 14% and adjusted EBITDA between $40,000,000 45,000,000 And adjusted EPS of $0.10 to $0.12 per share, bringing expectations for the full year of 2023 to revenue of $1,210,000,000 to $1,220,000,000 organic growth of high teens and adjusted EBITDA of $245,000,000 to 250,000,000 The update to our prior full year guidance is primarily a result of start up costs related to the launch of Juniper Re, A conservative view towards loss ratio sensitive contingents and the continuation of lower project based insurance revenue in IES, which began to manifest in Q3.